GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.

Pfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn patients about possible cancer risks caused by the anti-heartburn medication Zantac. The lawsuits ...

A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported. The case, brought by Illinois resident Ronald Kimbrow, alleged ...

Plaintiffs in Philadelphia's Zantac mass tort are asking the judge overseeing the litigation to recuse himself. The motion is based on the judge's wife's role as partner at a firm that represents a ...

Shares of GSK plc GSK, Haleon plc HLN and other pharma companies, such as Sanofi SNY and Pfizer Inc. PFE fell on Thursday after the news of potential litigation around the heartburn drug Zantac ...

Delaware's highest court said on Tuesday it will hear an appeal by GSK GSK.L and other drug makers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer.

An Illinois jury sided with drugmakers GlaxoSmithKline and Boehringer Ingelheim in the first trial over Zantac, which the FDA recalled in 2020 over claims the over-the-counter heartburn medication ...

(Reuters) - GSK agreed to confidentially settle another lawsuit in California that had alleged its discontinued heartburn drug Zantac caused cancer, the latest in a series of settlements made by the ...